165 related articles for article (PubMed ID: 32827133)
1. Molecular Adjuvants for DNA Vaccines: Application, Design, Preparation, and Formulation.
Sabbaghi A; Ghaemi A
Methods Mol Biol; 2021; 2197():87-112. PubMed ID: 32827133
[TBL] [Abstract][Full Text] [Related]
2. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
3. Flavivirus DNA Vaccine Design and Adjuvant Selection.
Li L; Honda-Okubo Y; Petrovsky N
Methods Mol Biol; 2021; 2183():405-422. PubMed ID: 32959256
[TBL] [Abstract][Full Text] [Related]
4. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
Marciani DJ
Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant formulations and delivery systems for DNA vaccines.
Sasaki S; Takeshita F; Xin KQ; Ishii N; Okuda K
Methods; 2003 Nov; 31(3):243-54. PubMed ID: 14511957
[TBL] [Abstract][Full Text] [Related]
6. Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.
Rose AH; Hoffmann FW; Hara JH; Urschitz J; Moisyadi S; Hoffmann PR; Bertino P
Hum Vaccin Immunother; 2015; 11(9):2305-11. PubMed ID: 26091088
[TBL] [Abstract][Full Text] [Related]
7. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques.
Halwani R; Boyer JD; Yassine-Diab B; Haddad EK; Robinson TM; Kumar S; Parkinson R; Wu L; Sidhu MK; Phillipson-Weiner R; Pavlakis GN; Felber BK; Lewis MG; Shen A; Siliciano RF; Weiner DB; Sekaly RP
J Immunol; 2008 Jun; 180(12):7969-79. PubMed ID: 18523260
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
[TBL] [Abstract][Full Text] [Related]
12. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants.
Kim JJ; Yang JS; Manson KH; Weiner DB
Vaccine; 2001 Mar; 19(17-19):2496-505. PubMed ID: 11257383
[TBL] [Abstract][Full Text] [Related]
13. Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae.
Aldon Y; Kratochvil S; Shattock RJ; McKay PF
J Immunol; 2020 Feb; 204(4):903-913. PubMed ID: 31915263
[TBL] [Abstract][Full Text] [Related]
14. Technical and regulatory hurdles for DNA vaccines.
Donnelly J; Berry K; Ulmer JB
Int J Parasitol; 2003 May; 33(5-6):457-67. PubMed ID: 12782047
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.
Calarota SA; Weiner DB
Immunol Rev; 2004 Jun; 199():84-99. PubMed ID: 15233728
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
17. Routing dependent immune responses after experimental R848-adjuvated vaccination.
van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
[TBL] [Abstract][Full Text] [Related]
18. Engineering of DNA vaccines using molecular adjuvant plasmids.
Sin JI; Kim J; Chattergoon M; Ayyavoo V; McCallus D; Ugen KE; Boyer JD; Weiner DB
Dev Biol (Basel); 2000; 104():187-98. PubMed ID: 11713819
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines--challenges in delivery.
Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
[TBL] [Abstract][Full Text] [Related]
20. Plasmids encoding protein aggregation domains act as molecular adjuvants for DNA vaccines.
Capitani M; Saade F; Havas KM; Angeletti M; Concetti F; Agas D; Sabbieti MG; Concetti A; Venanzi FM; Petrovsky N
Curr Gene Ther; 2014; 14(3):161-9. PubMed ID: 24828254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
